(3,4-Dichloro-2-methylphenyl)boronic acid, 95.0%, 1g

(2R,3S)-1-BENZHYDRYL-2-METHYLAZETIDIN-3-OL, 95.0%, 100mg

tert-Butyl 2,6-diazaspiro[3.4]octane-6-carboxylate, 95.0%, 1g

(Z)-6-fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one, 98%, 50mg

Ethyl 4-oxo-3,4-dihydroquinazoline-2-carboxylate, 98.0%, 1g

1-(6-Bromopyridin-3-yl)ethan-1-ol, 97%, 25g

tert-Butyl (1-(aminomethyl)cyclopropyl)carbamate, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 3.00 µm, 1 Piece(s)

4-(tert-Butoxycarbonylaminomethyl)piperidine, 97.0%, 25g

2-(1-(TERT-BUTOXYCARBONYL)-3-METHYLAZETIDIN-3-YL)ACETIC ACID, 95.0%, 5g

tert-Butyl N-[(1R)-1-(2-bromo-4-fluorophenyl)ethyl]carbamate, 98.0%, 1g

(+)-1,4-Di-O-benzyl-D-threitol>98.0%(GC)1g

1-Benzyl-3,3-difluoropiperidine-4,4-diol>98.0%(GC)(T)200mg